baber/WOPTO huggingface dataset:
Patent NZ-203408-A (NZ)
Title: Process and apparatus for bottom drainage of fluid-bed polymerisation reactor
Inventor: RANFAST C
IPC: B01J3/02
Filed: 1983-02-25
Abstract: The invention relates to a device and process permitting of the bottom drainage of a fluid-bed polymerization reactor (1) comprising a fluidization plate (2), a gas inlet (3) located between the said plate and the bottom of the reactor and a side pipe (4) located above the said plate and permitting of the evacuation of the fluidized particles, the said device consisting: of a vertical pipe (5) having a top opening at the level of the plate and a bottom end located outside and underneath the bottom of the reactor, which is occluded by a cock (6), and a gas intake tube (7) in the said vertical piping, leading out into the immediate vicinity of the said cock (6).
Patent NZ-206583-A (NZ)
Title: A process for the manufacture of a naturally carbonated beverage
Inventor: DARBYSHIRE J
IPC: C12G3/08
Filed: 1983-12-14
Abstract: A must is fermented with a combination of at least one yeast and at least one lactobacillus, the former being selected from the group of Saccharomyces cerevisiae and Kluyveromyces lactis and the latter being selected from the group of Lactobacillus casei and Lactobacillus hilgardii for their symbiotic ability and capability to produce a synergistic organoleptic effect which eliminates all after-taste of yeast. The must is inoculated such that the respective numbers of yeast germs and lactobacilli germs per ml have a ratio of from 1:10 to 1:500.
Patent NZ-207337-A (NZ)
Title: Human nerve growth factor (hngf), prepared by recombinant technology
Inventor: GRAY A M
IPC: C12P21/00
Filed: 1984-03-01
Abstract: The  beta -subunit of human nerve growth factor is prepared by recombinant DNA technology.
Patent NZ-209552-A (NZ)
Title: Double sided coating of upwardly moving web using two extrusion type applicators
Inventor: TUHKANEN R
IPC: B05C9/04
Filed: 1984-09-14
Abstract: An appliance for a double-sided coating of a moving web by means of two coating substance applicators and a smoothing nip comprising a back-up roll on one side of the web and a adjustable levelling blade or the like on the other side of the web. The coating substance is supplied on the web directly on the side facing the levelling blade and on the surface of the back-up roll or the web on the other side of the web. The smoothing nip and the both applicators are located within a 30 degrees sector of the back-up roll, preferably within a 20 degrees sector.
Patent NZ-212561-A (NZ)
Title: Heat exchange structure made of individual refractory shapes
Inventor: BARNA G L
IPC: F28D17/02
Filed: 1985-06-26
Abstract: A heat exchange structure is constructed from refractory blocks having three linearly aligned flue-forming openings extending from top to bottom of the block. The central opening is surrounded on four sides by refractory and the two end openings are surrounded on three sides. These refractory shapes are assembled in an open basketweave structure to form the heat exchanger. The resulting structure contains vertically extending, interconnected flues of two types, (1) flues of a first type interconnected at alternate layers in the structure to each of the four contiguously adjacent flues and (2) flues of a second type connected to opposed pairs of contiguously adjacent flues at alternate levels and to the other pair of contiguously adjacent flues at the intermediate levels. The net result is a stable heat exchange structure with relatively thin walls, relatively large flues, and means for creating turbulence in gas passing through the exchanger, thus increasing the rate of heat exchange.
Patent NZ-214066-A (NZ)
Title: 3-amino-2,3-dihydro-1-benzoxepine derivatives and pharmaceutical compositions
Inventor: OHLENDORF H W
IPC: A61K31/55
Filed: 1985-11-05
Abstract: 3-amino-2,3-dihydro-1-benzoxepine compounds corresponding to the general Formula I    <IMAGE>  I  wherein R1 and R2 may each be hydrogen, halogen, lower alkyl or lower alkoxy, or if one of R1 and R2 is hydrogen, the other may also be nitro or trifluoromethyl, R3 represents hydrogen or a lower alkyl group which optionally may be substituted by hydroxy, lower alnoxy, an optionally substituted phenyl group or an optionally substituted amino group, and R4 represents hydrogen or lower alkyl, or R3 and R4 together with the nitrogen atom form a 5 or 6 member heterocycle. The compounds exhibit pharmacological, especially antidepressive, activity.
Patent NZ-233404-A (NZ)
Title: Substituted 1h-1,2,3-triazolo(4,5-c)pyridine derivatives and pharmacuetical compositions
Inventor: KELLEY JAMES LEROY
IPC: A61K31/435
Filed: 1990-04-20
Abstract: There is disclosed a series of triazolopyrimidine compounds and pharmaceutical compositions containing them. The disclosed compounds are useful in the treatment of central nervous disorders, such as epilepsy, in mammals. Methods for the preparation of these triazolopyrimidines are also disclosed.
Patent NZ-234031-A (NZ)
Title: Inhalation device: includes vortex chamber with tangential inlet port
Inventor: LANKINEN TAPIO
IPC: A61M15/00
Filed: 1990-06-12
Abstract: A device for a more effective pulverization of particles and/or agglomerates of a powdered inhalation medicament, comprising a chamber (2) intended for medicament and substantially closed at one end thereof, said chamber being provided with at least one air inlet port and a powdered medicament outlet port. The chamber (2) substantially closed at one end said, chamber being rotationally symmetrical in shape or its cross-section perpendicular to the centre axis thereof being substantially circular in shape and without substantial flow obstacles. The inlet and outlet ports are spaced from each other in the direction of the centre axis of chamber (2). Said inlet port (1) being designed to direct the air inflow into the vortex chamber substantially parallel to the tangent of said chamber.
Patent NZ-241398-A (NZ)
Title: Influenza vaccine containing influenza virus core particles as an additive
Inventor: MOSTE-DESHAIRS CATHERINE
IPC: C07K14/11
Filed: 1992-01-24
Abstract: The use, when preparing a vaccine composition containing a standard influenza virus vaccine, of an additive which consists of a core or core fraction of at least one influenza virus, especially a fraction containing protein M; and a vaccine composition thereby obtained. The use of said additive improves the vaccine's effectiveness.
Patent NZ-243695-A (NZ)
Title: Iodinated ethers and their preparation
Inventor: FAIARDI DANIELA
IPC: A61P35/00
Filed: 1990-12-12
Abstract: Morpholinyl derivatives of doxorubicin having the general formula A:   <CHEM> wherein X represents a linear or branched C1-c6 alkyl group or a benzyl group -CH2C6H5, and having (S) or (R) configuration at carbon atom C-2" of the morpholino ring, are antitumor agents.
Patent NZ-245725-A (NZ)
Title: Drug conjugates containing an acylhydrazone link
Inventor: WILLNER DAVID
IPC: A61K47/48
Filed: 1993-01-21
Abstract: Provided are drug/ligand compounds of Formula (I): <CHEM>  in which   D is   a drug moiety; n is   an integer from 1 to 10; p is   an integer from 1 to 6; Y is   O or NH2<+>C1<->; z is   0 or 1; q is   about 1 to about 10; X is   a ligand; and, A is   a Michael Addition Adduct.   In a preferred embodiment, the ligand is an immunoglobulin, preferably a chimeric antibody or fragment thereof. Also provided are formulations comprising as an active ingredient a compound of Formula (I), intermediates useful for preparing the compounds of Formula (I), processes for preparing the compounds of Formula (I), and methods for using the compounds of the invention.
Patent NZ-246469-A (NZ)
Title: Diagnosing alzheimers and amyotrophic lateral sclerosis neurological diseases by photoaffinity labelling specific biochemical marker nucleotide binding proteins of 42 000 and 55 000 daltons respectively
Inventor: HALEY BOYD E
IPC: G01N33/573
Filed: 1992-12-23
Abstract: The present invention relates to a novel method for the diagnosis of Alzheimer's disease using cerebrospinal fluid. More particularly, this method consists in contacting a sample of cerebrospinal fluid which contains a glutamine synthetase, having an apparent MT of about 42 000 daltons, with a labeled antibody specific for said glutamine synthetase under conditions that allow the formation of glutamine synthetase-antibody complex formation ; detecting the presence of said glutamine synthetase-antibody complexes ; and correlating the presence of said complexes with the presence of Alzheimer's disease.
Patent NZ-253878-A (NZ)
Title: Dry flowable glyphosate compositions
Inventor: BEESTMAN GEORGE BERNARD
IPC: A01N25/12
Filed: 1993-06-10
Abstract: This invention relates to a dry flowable agricultural composition comprising glyphosate, an anhydrous base salt, and a heat activated binder that is prepared without a drying step even when the glyphosate is in the form of a wetcake.
Patent NZ-266235-A (NZ)
Title: Belt, for an absorbent garment, having hook element attachable and non-attachable zones
Inventor: RONNBERG PETER
IPC: A61F5/44
Filed: 1994-05-09
Abstract: PCT No. PCT/SE94/00425 Sec. 371 Date Nov. 7, 1995 Sec. 102(e) Date Nov. 7, 1995 PCT Filed May 9, 1994 PCT Pub. No. WO94/26225 PCT Pub. Date Nov. 24, 1994A belt for use with an absorbent garment generally for persons suffering from incontinence. The belt has two laterally spaced edges defining an area for releasable attachment of hook element strips of hook and loop type fastening elements. The belt also has only one defined portion, extending externally along a minor proportion of the length of the belt and across the major proportion of the width (z) of the belt, the defined portion being a non-attachment zone to which the hook elements cannot attach.
Patent NZ-272635-A (NZ)
Title: Laser cutting/drilling processing head that creates a vortex gas flow within the head to clean and prevent back spatting of particles onto the lens therein
Inventor: JAMES WILLIAM A
IPC: B23K26/14
Filed: 1995-07-24
Abstract: An improved laser processing head comprising a housing, a lens holder-nozzle mounted within the housing and a gas distributor for introducing gas adjacent a focusing lens retained within the housing to cool the lens and prevent the lens from becoming contaminated or damaged from material ablated from the workpiece. The gas distributor is comprised of a plurality of angled distribution slots that creates a vortex gas flow action directed away from the face of the lens and towards the nozzle outlet. <MATH>
Patent NZ-273258-A (NZ)
Title: Immunomodulator composition with components less than 3000 D that are extractable from bile, stimulate monocytes and macrophages and modulate TNF
Inventor: RANG ROMEO
IPC: A61K35/413
Filed: 1994-09-09
Abstract: he application relates to a composition for use as an immunomodulator comprising small molecular weight components of less than 3000 daltons, and having the following properties: a) is extractable from bile of animals; b) is capable of stimulating monocytes and macrophages in vitro; c) is capable of modulating tumor necrosis factor production; d) contains no measurable IL-1a, IL-1b, TNF, IL-6, IL-8, IL-4, GM-CSF or IFN-gamma; e) has an anti-proliferative effect in a malignant mouse hybridoma cell line; f) shows no cytotoxicity to human peripheral blood mononuclear cells; and g) is not an endotoxin. The application also relates to a method of preparing the composition and its use as an immunomodulator.
Patent NZ-283130-A (NZ)
Title: N-benzoylmethyl substituted paroxetine derivatives, preparation and pharmaceutical compositions thereof
Inventor: FOGUET RAFAEL
IPC: A61K31/445
Filed: 1995-03-17
Abstract: PCT No. PCT/EP95/01007 Sec. 371 Date Feb. 20, 1996 Sec. 102(e) Date Feb. 20, 1996 PCT Filed Mar. 17, 1995 PCT Pub. No. WO95/25732 PCT Pub. Date Sep. 28, 1995The invention relates to new N-benzoylmethyl-piperidines of the general formula (I):    <IMAGE>  (I)  wherein X is a halogen atom, as well as their pharmaceutically acceptable addition salts. The compounds are potentially useful to treat depressions.
Patent NZ-287214-A (NZ)
Title: Diagnosis and treatment of cardiovascular disease with dithiocarbamates
Inventor: MEDFORD RUSSELL M
IPC: A61K31/455
Filed: 1995-05-10
Abstract: A method of assess a test compound for its ability to treat a disorder mediated by VCAM-1 comprises evaluating the ability of the compound to inhibit the oxidation of a polyunsaturated fatty acid by: a) challenging a host to a high level of polyunsaturated fatty acid and b) determining the therapeutic efficacy of the test compound based in it ability to decrease the concentration of circulating or cell surface VCAM-1 concentration. Also disclosed is a method to assess a test compound for its ability to treat a disorder mediated by VCAM-1 by: c) exposing a polyunsaturated fatty acid to a protein and the test compound in an in vitro solution in the presence of a substance known to oxidize the polyunsaturated fatty acid in the absence of the test compound d) assessing the extent of interaction between the polyunsaturated fatty acid or oxidized polyunsaturated fatty acid and the protein.
Patent NZ-304433-A (NZ)
Title: Aspirating thermodynamic valve with a ferromagnetic, movable wall attracted to a magnet mounted on the body of the valve to control closing of the valve
Inventor: PASZKOWSKA MONIKA
IPC: F01L5/20
Filed: 1996-04-23
Abstract: PCT No. PCT/IB96/00362 Sec. 371 Date Oct. 28, 1997 Sec. 102(e) Date Oct. 28, 1997 PCT Filed Apr. 23, 1996 PCT Pub. No. WO96/34184 PCT Pub. Date Oct. 31, 1996An aspirating thermodynamic valve capable of controlling the flow of fuel mixture and air from the carburetor to the crankcase of a two-stroke engine includes a hollow body placed between the joint of the crankcase and the joint of the carburetor, along with suitably interpositioned seals. The valve includes a bush, the extremity of which is placed inside of the body and is cut out according to a predetermined inclination; furthermore, it includes a wall which is hinged by one end and is capable of closing the extremity.
Patent NZ-309980-A (NZ)
Title: Transdermal composition containing a blend of one or more polymers, one or more drugs that has a low molecular weight and is liquid at room temperature
Inventor: MANTELLE JUAN
IPC: A61P25/16
Filed: 1996-06-05
Abstract: A pressure-sensitive adhesive transdermal drug delivery system suitable for transdermal drug delivery comprising a blend of: (a) One or more solvent-based high shear resistant acrylic-based polymers having a shear resistance which is greater than or equal to 50 hours at 8 pounds per square inch and 72oF; and (b) A therapeutically effective amount of one or more drugs, at least one of which is of low molecular weight and liquid at or about room temperatures, wherein the transdermal drug delivery system forms a polymer matrix which has sufficient tack and shear to remain in place under conditions of use. The transdermal drug delivery system provides for a high drug loadable system where excessive plasticising of the polymer or polymers does not occur.
Patent NZ-331196-A (NZ)
Title: Water soluble fabric softener compositions comprising phthalocyanine, a quaternary ammonium compound and a photobleaching agent
Inventor: HOHENER ALFRED
IPC: D06L3/12
Filed: 1998-07-31
Abstract: fabric softner composition useful in obtaining good bleaching effects comprising: a)	a water-soluble phthalocyanine of Zn, Fe(II), Ca, Mg, Na, K, Al, Si(IV), P(V), Ti(IV), Ge(IV), Cr(VI), Ba(III), Zr(IV), In(IV) or Hf(VI); and b)	a quaternary ammonium compound of formula (I) in which: R1 and R2 independently of one another are C1-C5alkyl; or hydroxy-C1-C5alkyl and A is the radical of formula (1a) of (1b)  Where B is C1-C5alkyl; a C8-C20 fatty acid; the radical of formula (1a) or the radical of the formula (1b); R3, R4 and R5 independently of one another are a C8-C20 fatty acid radical; X1- is a softner-compatible anion; m, n and p are numbers from 0 to 5.
Patent NZ-334792-A (NZ)
Title: Copy holder having a document holding stand and an adjustable support means
Inventor: WELLS JOHN STUART
IPC: A47B23/04
Filed: 1997-10-01
Abstract: A copy holder (1) is provided with a document holding stand (2) supported adjustably by support means (3) to provide a stable support while allowing operator controlled, incremental adjustment through a working range to vary the angle at which the document holding stand (2) is supported.  The adjustable support means (3) is provided by spring clutches (11) on either end of a shaft (10) which can be releasably held in housings (8, 9) attached to the document holding stand (2) and these points of attachment together with a back support means (12) provide for stable support with the incremental adjustment effected by releasing the spring clutch (11) to adjust the gripping position on the shaft (10) relative to the point of attachment for the back support means (12).
Patent NZ-336908-A (NZ)
Title: Substrates for human cytomegalovirus protease
Inventor: BONNEAU PIERRE R
IPC: C12Q1/37
Filed: 1997-12-23
Abstract: The fluorogenic and radiometric peptide substrates for Human Cytomegalovirus (HCMV) are modelled on the maturation site of the enzyme and have the formula; X-Tbg-Tbg-Y-Ala-Z Particular examples of the substrates include; ABz-Tbg-Tbg-Asn(Me)2-Ala-Ser-Ser-Arg-Leu-Tyr(3-NO2)-Arg-OH  N-acetyl-Tbg-Tbg-Asn(Me)2-Ala-AMC dBiotin-Arg-Gly-Tbg-Tbg-Asn(Me)2-Ala-Ser-Ser-Arg-Leu-Ala-Tyr-NH2 Ac-Tbg-Tbg-Asn(Me)2-Ala-pNP Ac-Tbg-Tbg-Asn(Me)2-Ala-pNA These substrates may be used in assays for evaluating and characterizing HCMV protease inhibitors.
Patent NZ-500644-A (NZ)
Title: Azacyclooctane and azacycloheptane derivatives useful as nicotinic ACh receptor modulators
Inventor: PETERS DAN
IPC: A61K31/395
Filed: 1998-05-29
Abstract: A compound having the formula 1 or 2, any of its enantiomers, or a pharmaceutically acceptable salt thereof, wherein: n is 0 or 1; R is H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl; and R1 is i) a monocyclic 5 to 6-membered heteroaryl group which may be substituted one or more times with substituents selected from the group consisting of alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, thioalkoxy, thiocycloalkoxy, methylenedioxy, aryloxy cycloalkoxy, halogen, CF3, OCF3, CN, amino, nitro, aryl and a monocyclic 5 to 6-membered heteroaryl group; or ii) a bicyclic heteroaryl group composed of a monocyclic 5 to 6-membered heteroaryl group fused to a benzene ring and which may be substituted one or more times with substituents selected from the group consisting of alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, thioalkoxy, thiocycloalkoxy cycloalkoxy, methylenedioxy, aryloxy, halogen, CF3, OCF3, CN, amino, nitro, aryl and a monocyclic 5 to 6 membered heteroaryl group, provided however that the compound is not: hexahydro-2-(3-pyridinyl)-1H-azepine; 3,4,5,6-tetrahydro-7-(3-pyridinyl)-2H-azepine; hexahydro-1-methyl-2-(S)-(3-pyridinyl)-1H-azepine; Also described is a pharmaceutical composition comprising a therapeutically effective amount of the compound described above, or a pharmaceutically acceptable addition salt thereof, together with at least one pharmaceutically acceptable carrier or diluent. Also described is the use of the compound described above in the manufacture of a medicament for the treatment of a disease of a living animal body, including a human, which disease is responsive to the activity of nicotinic ACh receptor modulators.  Examples of these diseases are pain, central nervous system diseases (such as Alzheimer's disease, Parkinson's disease, memory dysfunction or ADHD), a disease caused by smooth muscle contraction, neurodegeneration, inflammation, chemical substance (such as nicotine-containing substances) abuse or withdrawal symptoms caused by the cessation of intake of the chemical substance.
Patent NZ-500825-A (NZ)
Title: Time slice allocation for packet transmission for packet switched data transmission
Inventor: HIPPELAINEN LEO
IPC: H04L12/56
Filed: 1998-05-12
Abstract: A method for the packet-switched transmission of calls and particularly real-time speech calls allows efficient use of the transmission capacity without impairing the quality of real-time calls so that the transmission delays remain short and the transmission delay of one and the same call does not vary at the receiving end. The method includes defining a repetition period that is longer than the duration of the transmission of a single packet, and allocating time slices of a different length from the repetition period for the connections. The starting point of the repetition period is defined, and information regarding the current point of the repetition period, the time slices allocated from the repetition period and the connections associated with them, are maintained. When a packet is received, the connection associated with the packet as well as the destination address of the packet is identified from the identification data of the packet, and whether or not a time slice has been allocated for the connection of the packet from the repetition period is checked. If such a time slice has been allocated the packet transmission is started when the starting point of the allocated time slice is reached in the repetition period. If no such time slice is allocated, the duration of the packet transmission time is defined and the repetition period is searched for a free period that is at least as long as the transmission time, and a time slice from this free period is allocated for the connection of the packet.
Patent NZ-501847-A (NZ)
Title: Production and tracking of tangible mail items using electronic email systems
Inventor: HARRIS CHRISTOPHER JOHN
IPC: G06F19/00
Filed: 1999-12-16
Abstract: A hybrid mail system where an electronic mail form is created at the user's computer and transmitted via the Internet to an output computer where the mail is produced in a physical form. Status information for each mail item is determined at the output computer and the information is transmitted back to the user where the user can track the processing of the items. The user can control the production process and send instructions to cancel the delivery of a mail item.
Patent NZ-504697-A (NZ)
Title: Microfluidic transport with subject material slugs separated in channels by spacer slugs of different ionic strengths
Inventor: PARCE WALLACE J
IPC: G01N27/416
Filed: 1997-06-25
Abstract: A microfluidic system for moving a number of materials from one location to another along a channel is disclosed. The system comprises a source for creating a voltage difference between the locations, a number of materials in the channel separated by spacers of high ionic strength and at least one spacer of low ionic strength.
Patent NZ-505321-A (NZ)
Title: Strip guiding apparatus and associated method for maintaining lateral position
Inventor: LAUGHERY HARRY E
IPC: B65H23/06
Filed: 1998-11-20
Abstract: Strip guiding apparatus (2) and method for maintaining a desired lateral position of a strip (10).  A roll (4) is rotatable about its longitudinal axis over which the strip (10) will travel while under tension.  Sensing apparatus (70) determines the lateral position of the strip (10) with respect to the desired position and emits signals to control apparatus (80) which will effect responsive rotation of a second axis (30), which is spaced from and oriented generally perpendicular to the roll (4) longitudinal axis and rotatable on support apparatus (40), in order to effect lateral movement of the roll (4) and therefore movement of the strip in relation to the desired position.  Pressure sensing apparatus (72) is provided for measuring strip (10) tension and emitting signals to tension controlling apparatus (104,106,114) to adjust tension when it is not within a desired range.
Patent NZ-506580-A (NZ)
Title: Combination of lanolin and glyceryl trinitrate for the treatment of erectile dysfunction
Inventor: KEMP COLIN ANTHONY
IPC: A61K47/44
Filed: 1999-01-28
Abstract: Use of glyceryl trinitrate and lanolin in the manufacture of a medicament for the treatment of erectile dysfunction.